{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T07:20:57Z","timestamp":1792653657124,"version":"4.5.0"},"reference-count":24,"publisher":"FapUNIFESP (SciELO)","issue":"11","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"am","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Rev. Assoc. Med. Bras."],"abstract":"<jats:p>SUMMARY  OBJECTIVE: Placental insufficiency, which plays a crucial role in both preeclampsia and fetal growth restriction, can cause oxidative stress and high reactive oxygen species production that could lead to hypoxia. Carbonic anhydrase IX is induced by hypoxia-inducible factor-1\u03b1, an important transcriptional regulator of genes involved in response to hypoxia. Considering this, we aimed to determine carbonic anhydrase IX levels in early preeclampsia with and without fetal growth restriction, and also to evaluate the predictive role of carbonic anhydrase IX for the development of fetal growth restriction in early onset preeclampsia.  METHODS: This prospective study included a total of 180 participants, who were divided into two groups\u2014early onset preeclampsia (n=90) and control (n=90). Then, preeclamptic patients were followed and subgrouped as preeclampsia with fetal growth restriction (n=35) and without fetal growth restriction (n=55). Sociodemographic and obstetric characteristics and laboratory features including carbonic anhydrase IX were compared between groups.  RESULTS: Median carbonic anhydrase IX was higher in preeclampsia than controls [2.07 (0.78\u20135.48) vs. 1.32 (0.63\u20132.12), p&lt;0.001]. Moreover, median carbonic anhydrase IX was higher in the preeclampsia with fetal growth restriction group as compared to the preeclampsia without fetal growth restriction group [2.76 (0.78\u20135.48) vs. 1.77 (0.89\u20135.14), p=0.018]. The carbonic anhydrase IX &gt;1.83 pg\/mL predicted fetal growth restriction with 77.14% sensitivity and 52.73% specificity (p=0.015, AUC=0.649) in the early onset preeclampsia.  CONCLUSION: Carbonic anhydrase IX could reflect the insufficiency of the placenta in early onset preeclampsia and fetal growth restriction, and it could be used in early onset preeclampsia patients for the prediction of fetal growth restriction.<\/jats:p>","DOI":"10.1590\/1806-9282.20250838","type":"journal-article","created":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T15:05:58Z","timestamp":1764947158000},"source":"Crossref","is-referenced-by-count":2,"title":["Could carbonic anhydrase IX predict fetal growth restriction in early onset preeclampsia?"],"prefix":"10.1590","volume":"71","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7888-7583","authenticated-orcid":false,"given":"Gulten","family":"Ozgen","sequence":"first","affiliation":[{"name":"University of Health Sciences,  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2697-7501","authenticated-orcid":false,"given":"Burcu","family":"Dincgez","sequence":"additional","affiliation":[{"name":"University of Health Sciences,  Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"530","published-online":{"date-parts":[[2025]]},"reference":[{"issue":"4","key":"ref1","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1038\/s41440-024-01586-x","article-title":"Association between human blood metabolome and the risk of pre-eclampsia","volume":"47","author":"Ding Y","year":"2024","journal-title":"Hypertens Res"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.placenta.2024.04.008","article-title":"Assessment of feto-placental oxygenation and perfusion in a rat model of placental insufficiency using T2* mapping and 3D dynamic contrast-enhanced MRI","volume":"151","author":"Darwish FM","year":"2024","journal-title":"Placenta"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.placenta.2021.09.013","article-title":"Oxidative stress biomarkers in fetal growth restriction with and without preeclampsia","volume":"115","author":"Schoots MH","year":"2021","journal-title":"Placenta"},{"issue":"2","key":"ref4","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1081\/PRG-120028292","article-title":"Markers for presymptomatic prediction of preeclampsia and intrauterine growth restriction","volume":"23","author":"Tjoa ML","year":"2004","journal-title":"Hypertens Pregnancy"},{"issue":"2","key":"ref5","first-page":"79","article-title":"Maternal serum fractalkine concentrations in pregnancies complicated by fetal growth restriction","volume":"29","author":"Toprak Sager EB","year":"2023","journal-title":"Gynecol Obstet Reprod Med"},{"issue":"9","key":"ref6","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.3390\/cells11091413","article-title":"The placental NLRP3 inflammasome and its downstream targets, caspase-1 and interleukin-6, are increased in human fetal growth restriction: implications for aberrant inflammation-induced trophoblast dysfunction","volume":"11","author":"Alfian I","year":"2022","journal-title":"Cells"},{"issue":"14","key":"ref7","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.3390\/cancers14143297","article-title":"Cancer therapeutic targeting of hypoxia induced carbonic anhydrase IX: from bench to bedside","volume":"14","author":"McDonald PC","year":"2022","journal-title":"Cancers (Basel)"},{"issue":"5","key":"ref8","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1007\/s12033-023-01021-5","article-title":"Preclinical evaluation of virus-like particle vaccine against carbonic anhydrase IX efficacy in a mouse breast cancer model system","volume":"66","author":"Kalni\u0146a Z","year":"2024","journal-title":"Mol Biotechnol"},{"issue":"10","key":"ref9","doi-asserted-by":"crossref","first-page":"3116","DOI":"10.1007\/s00259-023-06248-7","article-title":"Preclinical and pilot clinical evaluation of a small-molecule carbonic anhydrase IX targeting PET tracer in clear cell renal cell carcinoma","volume":"50","author":"Zhu W","year":"2023","journal-title":"Eur J Nucl Med Mol Imaging"},{"issue":"1","key":"ref10","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s13000-023-01325-9","article-title":"The relationship between carbonic anhydrase IX (CAIX) and patient survival in breast cancer: systematic review and meta-analysis","volume":"18","author":"Shamis SAK","year":"2023","journal-title":"Diagn Pathol"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"1075604","DOI":"10.3389\/fmolb.2023.1075604","article-title":"Early increase in circulating carbonic anhydrase IX: a potential new predictive biomarker of preeclampsia","volume":"10","author":"Galbiati S","year":"2023","journal-title":"Front Mol Biosci"},{"issue":"6","key":"ref12","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1093\/ndt\/gfab175","article-title":"Renal dysfunction and podocyturia in pre-eclampsia may be explained by increased urinary VEGF","volume":"37","author":"Valsecchi L","year":"2022","journal-title":"Nephrol Dial Transplant"},{"issue":"11","key":"ref13","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.17219\/acem\/74653","article-title":"Circulating parameters of oxidative stress and hypoxia in normal pregnancy and HELLP syndrome","volume":"27","author":"Mentese A","year":"2018","journal-title":"Adv Clin Exp Med"},{"key":"ref14","series-title":"Gestational hypertension and preeclampsia: ACOG practice bulletin, number 222","first-page":"e237","volume":"135","year":"2020"},{"issue":"3","key":"ref15","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1002\/uog.15884","article-title":"Consensus definition of fetal growth restriction: a Delphi procedure","volume":"48","author":"Gordijn SJ","year":"2016","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref16","series-title":"The Fetal Medicine Foundation, assessment of fetal growth and fetal doppler"},{"issue":"16","key":"ref17","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.3390\/cells12162080","article-title":"From molecules to imaging: assessment of placental hypoxia biomarkers in placental insufficiency syndromes","volume":"12","author":"Al Darwish FM","year":"2023","journal-title":"Cells"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.placenta.2022.12.009","article-title":"Evaluation of oxidative stress markers in subtypes of preeclampsia: a systematic review and meta-analysis","volume":"132","author":"Freire VAF","year":"2023","journal-title":"Placenta"},{"issue":"6","key":"ref19","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1002\/uog.20272","article-title":"ISUOG practice guidelines: ultrasound assessment of fetal biometry and growth","volume":"53","author":"Salomon LJ","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.placenta.2021.09.013","article-title":"Oxidative stress biomarkers in fetal growth restriction with and without preeclampsia","volume":"115","author":"Schoots MH","year":"2021","journal-title":"Placenta"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.placenta.2021.03.018","article-title":"Placental hypoxia: what have we learnt from small animal models?","volume":"113","author":"Siragher E","year":"2021","journal-title":"Placenta"},{"issue":"3","key":"ref22","doi-asserted-by":"crossref","first-page":"166","DOI":"10.21613\/GORM.2018.918","article-title":"Neutrophil gelatinase-associated lipocalin levels in early and late onset preeclampsia","volume":"26","author":"Guralp O","year":"2020","journal-title":"Gynecol Obstet Reprod Med"},{"issue":"3","key":"ref23","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1097\/FM9.0000000000000161","article-title":"Fetal growth restriction: mechanisms, epidemiology, and management","volume":"4","author":"Kamphof HD","year":"2022","journal-title":"Matern Fetal Med"},{"issue":"5","key":"ref24","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00404-017-4341-9","article-title":"Fetal growth restriction: current knowledge","volume":"295","author":"Nardozza LM","year":"2017","journal-title":"Arch Gynecol Obstet"}],"container-title":["Revista da Associa\u00e7\u00e3o M\u00e9dica Brasileira"],"original-title":[],"link":[{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_pdf&pid=S0104-42302025001100610&tlng=en","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,5]],"date-time":"2025-12-05T15:06:01Z","timestamp":1764947161000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.scielo.br\/scielo.php?script=sci_arttext&pid=S0104-42302025001100610&tlng=en"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025]]},"references-count":24,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025]]}},"alternative-id":["S0104-42302025001100610"],"URL":"https:\/\/doi.org\/10.1590\/1806-9282.20250838","relation":{},"ISSN":["1806-9282","0104-4230"],"issn-type":[{"value":"1806-9282","type":"electronic"},{"value":"0104-4230","type":"print"}],"subject":[],"published":{"date-parts":[[2025]]},"article-number":"e20250838"}}